Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 0 | 0 |
% | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] VSAL has posted erratic financial performance so far. It is priced exorbitantly based on its latest performance with super-profits. It is going to spend nearly 80% of IPO proceeds on advertising and branding which raises concern. There is no harm in ignoring this IPO. Read detail review...
Vaidya Sane Ayurved Laboratories IPO Reviews, analysis and views by popular members. Read Vaidya Sane Ayurved Laboratories Ltd. IPO reviews by retail investors to find recommended ipo to buy.
Review By | Apply | May Apply | Neutral | Avoid |
---|---|---|---|---|
Count | 0 | 0 | 0 | 0 |
% | 0.00 | 0.00 | 0.00 | 0.00 |
Member | Review |
---|---|
No recommendation found. Be the first to post the recommendation. |
Note:
Useful Articles